Article
HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Mar 2017
Dominguez-Molina B, Tarancon-Diez L, Hua S, Abad-Molina C, Rodriguez-Gallego E, Machmach K, Vidal F, Tural C, Moreno S, Goñi J M, Ramírez de Arellano E, Del Val M, Gonzalez-Escribano M F, Del Romero J, Rodriguez C, Capa L, Viciana P, Alcamí J, Yu X G, Walker B D, Leal Manuel, Lichterfeld M, Ruiz-Mateos E
Abstract excerpt
Background: HIV-1-controllers maintain HIV-1 viremia at low levels (normally <2000 HIV-RNA copies/mL) without antiretroviral treatment. However, some HIV-1-controllers have evidence of immunologic progression with marked CD4+T-cell decline. We investigated host genetic factors associated with protection against CD4+T-cell loss in HIV-1-controllers. Methods: We analysed the association of interferon lambda 4...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
